Display options
Share it on

Am J Med. 2021 Aug;134(8):968-975. doi: 10.1016/j.amjmed.2021.03.011. Epub 2021 Apr 20.

Myocardial Perfusion and Viability Imaging in Coronary Artery Disease: Clinical Value in Diagnosis, Prognosis, and Therapeutic Guidance.

The American journal of medicine

Dan L Li, Marvin W Kronenberg

Affiliations

  1. Division of Cardiovascular Medicine, Department of Medicine, Vanderbilt University Medical Center, Nashville, Tenn.
  2. Division of Cardiovascular Medicine, Department of Medicine, Vanderbilt University Medical Center, Nashville, Tenn. Electronic address: [email protected].

PMID: 33864764 DOI: 10.1016/j.amjmed.2021.03.011

Abstract

Coronary artery disease is a leading cause of morbidity and mortality worldwide. Noninvasive imaging tests play a significant role in diagnosing coronary artery disease, as well as risk stratification and guidance for revascularization. Myocardial perfusion imaging, including single photon emission computed tomography and positron emission tomography, has been widely employed. In this review, we will review test accuracy and clinical significance of these methods for diagnosing and managing coronary artery disease. We will further discuss the comparative usefulness of other noninvasive tests-stress echocardiography, coronary computed tomography angiography, and cardiac magnetic resonance imaging-in the evaluation of ischemia and myocardial viability.

Copyright © 2021 The Authors. Published by Elsevier Inc. All rights reserved.

Keywords: Coronary artery disease; Coronary computed tomography angiography; Myocardial ischemia; Myocardial perfusion imaging; Myocardial viability; Positron emission tomography; Single photon emission computed tomography

MeSH terms

Publication Types